Top Tips for Cost Effective Integration of Predictive Toxicology
Add bookmarkTop Tips for Cost Effective Integration of Predictive Toxicology
Add bookmarkWith budget cuts hitting hard in the R&D field, it is imperative to validate the worth of predictive methods internally as they continue to facilitate the reduction in late stage drug attrition. But the challenges remain: how do we cost-effectively develop and implement these in-vitro methods as accurately and as early in the drug discovery process as possible?
Jorrit J. Hornberg, PhD Head of Section In Vitro Studies, Exploratory Toxicology at Lundbeck, speaks to Andrea Charles from Pharma IQ, about the biggest
developments and challenges in predictive toxicology, cost effective integration of predictive toxicology and future perspectives in the next 10 years.
[inlinead]
| Have Your Say Rate this feature and give us your feedback in the comments section below |